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Type 2 Diabetes (T2D)
Janice Loney BSN, RN
.
• Type 2 diabetes (T2D)  is long-term, chronic 
condition affecting the way the body 
processes glucose.
• More common than type 1 diabetes, T2D 
involves the body not producing enough 
insulin or resistance to insulin (Leonitis & 
Hess-Fischl, 2019).
• Previously considered adult onset, evidence  
reveals increased prevalence of T2D in 
children, contributing to the growing 
number of 29.1 million people in the US with 
this disease (Cornell, 2015).
• A progressive disease, T2D predisposes 
individuals to heart disease, stroke, 
retinopathy, neuropathy, dementia, renal 
disease, amputation and early death (Skyler 
et al., 2017).
• Risk of developing T2D increases after age 40 
(McCance & Huether, 2019).
• People with T2D spend more on healthcare, 
have fewer productive years and miss more 
work days compared to people who don’t 
have T2D. 
• In the last 20 years, the number of adults 
diagnosed with diabetes has more than 
tripled as the US population has aged and 
become more overweight (“Type 2 Diabetes-
Data & Statistics,” 2019). 
• Diabetes care has a major economic impact 
worldwide, as a future family nurse 
practitioner (FNP) patient education  on T2D 
risk factors, disease process and medical 
management  are vital to halt this growing 
epidemic.  







• Blurred vision 
• Recurrent infections
• Poor wound healing
• Weight loss
• Areas darkened skin,, usually in armpits 
and neck
• Possibly asymptomatic
Leonitis & Hess-Fischl, 2019 
Signs & Symptoms  
• Working in a Case Management role, this graduate nurse 
experiences first hand recurrent  hospitalizations requiring 
patient education, utilization of resources and support to 
manage diabetes.  C.P. is a 52-year-old man who most recently 
presented with A-fib, , neuropathy, open sores on both feet, 
hypertension, obesity as well as being a smoker.  Initial blood 
glucose  was 243 and when asked about home medications for 
diabetes patient exclaimed, “I don’t have diabetes, my blood 
sugar is just high”.  Treatment of  dysrhythmia, regulation of 
blood glucose, levels, treatment of open wounds required 
medication therapies and education.  
• Obesity contributes to insulin resistance whereby serum levels 
of leptin, adiponectin and inflammation affect insulin synthesis 
and resistance (McCance & Huether, 2019).  
• People with diabetes who smoke have increased risk of serious 
complications, such as heart disease, kidney disease, and poor 
blood flow in legs and feet predisposing them to  infections and 
neuropathy.
• Collaborative education with  a Diabetic Educator involved 
obtaining glucometer with education on use, storage of 
supplies, medication compliance, diet & lifestyle modifications 
as well as the importance of smoking cessation.
• Established patient with Chronic Care Management team for 
ongoing education, support and symptom management  for 
overall health.  
• Understanding T2D: food digested is used as fuel (glucose) for 
the body’s cells.
• Glucose requires the hormone insulin to enter the cells.
• Produced by the pancreas, insulin is released into the 
bloodstream in response to the presence of glucose. 
• In T2D, cells don’t  respond properly to insulin, therefore less 
glucose moves into cells (insulin resistance)
• Less glucose entering cells produces buildup of glucose in 
bloodstream (hyperglycemia).
Insulin Resistance
https://www.krames ondemand.com/HealthS heet.aspx? id
=89525&ContentTypeId=3
Risk Factors
Ley et al., 2016
Underlying Pathophysiology
McCanc e & Huether, 2019, p. 690
• Abnormalities of insulin signaling pathway with gradual progression.
• Pancreatic beta cell function= ability to sense blood glucose level, insulin synthesis and 
secrete insulin.
• Insulin necessary to unlock cells, thereby promoting glucose removal from the blood.
• Cells in muscle, liver and adipose tissue ineffective at absorbing insulin, likewise cannot 
regulate glucose levels (Brunton, 2016, p.3).
• Inability of cells to respond to insulin leads to insulin resistance.
• Hormones in GI tract  such as amylin and ghrelin are diminished in T2D, thereby slowing 
gastric emptying, GI motility and  promoting hunger.   
• Impaired regulation of hepatic glucose, the liver overproduces glucose due to developed 
resistance to suppressive effect of insulin.   
• Insulin resistance develops with ectopic fat deposition in the liver and muscle.
• Accumulation of fat in the pancreas contributes to decline in beta cell function, islet 
inflammation and eventual beta cell death (Skyler et al., 2017, p. 244).
• High levels of glucose in blood signal pancreas to secrete more insulin
• As disease progresses, pancreas is unable to keep up with the demand  which leads to 
insulin insufficiency and finally hyperglycemia
Brunton, 2016
• Obesity
• Family history- 40% greater if one  
parent has the disease
• Age, older than 45 years
• Physical inactivity
• Hypertension
• Diet/diet during pregnancy
• Male sex higher prevalence than female
• Metabolic syndrome




• Ethnicity (Black, Pacific Islander, Asian 
American, or Native American)
• Low socioeconomic status
Significance of Underlying Pathophysiology 
• Chronic hyperglycemia leads to CAD, PAD, CVD ( Brunton,  2016).
• Blood vessels damaged by consistent hyperglycemia lead to cataracts and retinopathy in the
eyes, likewise diabetic neuropathy develops when blood vessels in nerves undergo damage.
• Peripheral neuropathy is loss of sensation in hands and more commonly feet from chronic nerve 
damage which leads to undetected sores predisposing individuals to infections.
• Gluconeogenesis occurs in the kidneys and liver, further exacerbating hyperglycemia. 
• Diabetic nephropathy may develop as the kidneys are unable to filter impurities from blood 
(Skyler et al., 2017).
• Medications to treat T2D along with dietary management may lead to hypoglycemia as blood 
glucose levels regulate.
McCance & Huether,  2019
• Patient and family education regarding disease process , signs and symptoms of  
hyper/hypoglycemia and prevention of  T2D complications.
• Screening for at risk individuals  to prevent or delay progression of T2D (Skyler et al., 2016).
• Nutritional management for balanced and healthy diet promotes glycemic control and 
healthy weight improving insulin sensitivity.
• Personalized approach for a regular exercise regimen thereby encouraging weight loss.
• Monitor one’s feet, skin and eyes via annual check-up with their healthcare provider.
• Lab testing of blood and urine to check A1C, ketones in urine and cholesterol levels.
• Education on necessary diabetic supplies; glucometer, test strips, syringes/needles and 
proper storage/disposal for optimal use. 
• Regular self -monitoring of blood glucose and tracking for target range.
• Instruction on medication administration, oral medication and insulin if needed. 
• Coaching on support services and programs such as, Diabetes Self-management Education 
and Support Services (DSMES) provide a tailored approach to care utilizing  evidence-based 
standards  (“Managing Diabetes,” 2018). 
• Referral to resource The American Diabetes Association (ADA) at 800-342-2383 or 
www.diabetes.org. 
• Education on smoking cessation in conjunction with  nicotine replacement therapy to 
prevent further complications associated with T2D. 
• Utilization/implementation of telehealth delivery of care supports patients in rural areas, 
where diabetes incidence is 17% more prevalent (“Type 2 Diabetes-Data & Statistics,” 2019). 
Implications for Nursing Care
• T2D is a chronic condition and if not properly managed can result in serious health 
complications and death.
• Approximately 29.1 million people in the USA have diabetes; if  current trend continues 
percentage is estimated to be 592 million people worldwide by 2035 (Cornell, 2015).
• Early diagnosis impacts  the severity of disease.  The treatment goal is restoration of 
normal blood glucose and correction of related metabolic disorders.  
• In 2016, the CDC partnered with the ADA, the American Medical Association and the Ad 
Council  promoting  the first prediabetes awareness campaign.   Sites such as,
DoIHavePrediabetes .org allows people to inquire their risk of diabetes through quick 
test as well as providing links to nationwide sites for valuable information to improve 
health.  
• Prevention is best, however once diagnosed with T2D managing disease involves lifestyle 
and dietary changes with  support of healthcare professionals  that promote
health and improve quality of life. 
Conclusion
